NCT05485610View on ClinicalTrials.gov

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Diminished Ovarian ReservePremature Ovarian Insufficiency
Interventions
DIETARY_SUPPLEMENT

NMN intervention

NMN capsules (total of 600mg/day) for 3 months

OTHER

Placebo

NMN-free placebo capsules for 3 months

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER